Home
>
National Drug Code (NDC)
>
Synercid
Synercid - 61570-260-10 - (quinupristin and dalfopristin)
Drug Information of Synercid
| Product NDC: | 61570-260 |
| Proprietary Name: | Synercid |
| Non Proprietary Name: | quinupristin and dalfopristin |
| Active Ingredient(s): | 350; 150 mg/5mL; mg/5mL & nbsp; quinupristin and dalfopristin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Synercid
| Product NDC: | 61570-260 |
| Labeler Name: | Monarch Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050748 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19990921 |
Package Information of Synercid
| Package NDC: | 61570-260-10 |
| Package Description: | 10 VIAL, GLASS in 1 CARTON (61570-260-10) > 5 mL in 1 VIAL, GLASS |
NDC Information of Synercid
| NDC Code | 61570-260-10 |
| Proprietary Name | Synercid |
| Package Description | 10 VIAL, GLASS in 1 CARTON (61570-260-10) > 5 mL in 1 VIAL, GLASS |
| Product NDC | 61570-260 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | quinupristin and dalfopristin |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19990921 |
| Marketing Category Name | NDA |
| Labeler Name | Monarch Pharmaceuticals, Inc. |
| Substance Name | DALFOPRISTIN; QUINUPRISTIN |
| Strength Number | 350; 150 |
| Strength Unit | mg/5mL; mg/5mL |
| Pharmaceutical Classes | Streptogramin Antibacterial [EPC],Streptogramins [Chemical/Ingredient],Streptogramin Antibacterial [EPC],Streptogramins [Chemical/Ingredient] |
